"Personalized medicine: elusive dream or imminent reality?": A commentary

Clin Pharmacol Ther. 2007 Jun;81(6):801-5. doi: 10.1038/sj.clpt.6100227.

Abstract

I was invited to comment on the article in this issue by Larry Lesko, "Personalized Medicine: Elusive Dream or Imminent Reality?",(1) especially with respect to three questions. There are several possible approaches to discussing these questions. One is to simply answer the question as directly and succinctly as possible; another is to expand on the questions. For the purpose of this Commentary, I try to do both.

Publication types

  • Comment

MeSH terms

  • Anti-HIV Agents / adverse effects
  • Anti-HIV Agents / therapeutic use
  • Biomedical Research / methods*
  • Dideoxynucleosides / adverse effects
  • Dideoxynucleosides / therapeutic use
  • Drug Industry / economics
  • Drug Industry / standards*
  • Drug-Related Side Effects and Adverse Reactions*
  • Humans
  • Molecular Diagnostic Techniques
  • Pharmaceutical Preparations / administration & dosage*
  • Pharmacogenetics
  • Product Surveillance, Postmarketing
  • Prospective Studies
  • Randomized Controlled Trials as Topic

Substances

  • Anti-HIV Agents
  • Dideoxynucleosides
  • Pharmaceutical Preparations
  • abacavir